Another monoclonal CD40 antibody termed BI 655064 was already tested in phase 1 and 2a as a potential treatment agent for several autoimmune diseases like rheumatoid arthritis, systemic lupus erythematosus or lupus nephritis. This evidence concerns the gene CD40 and autoimmune disease.